z-logo
open-access-imgOpen Access
Increase in Adverse Health Effects Related to Synthetic Cannabinoid Use
Author(s) -
Royal Law,
Josh Schier,
Colleen Martin,
Arthur Chang,
Amy Wolkin,
Jay L. Schauben
Publication year - 2016
Publication title -
online journal of public health informatics
Language(s) - English
Resource type - Journals
ISSN - 1947-2579
DOI - 10.5210/ojphi.v8i1.6479
Subject(s) - adverse effect , medicine , cannabinoid , data science , bioinformatics , computer science , pharmacology , biology , receptor
Synthetic cannabinoids include various psychoactive chemicals that are sprayed onto plant material, which is then smoked or ingested to achieve a “high.” These products are sold under a variety of names (e.g., synthetic marijuana, spice, K2, black mamba, and crazy clown) and are sold in retail outlets as herbal products and are often labeled not for human consumption. Law enforcement agencies regulate many of these substances; however, manufacturers may frequently change the formulation and mask their intended purpose to avoid detection and regulation. On April 6, 2015, automated surveillance algorithms via surveillance through the National Poison Data System (NPDS), a web-based surveillance system of all calls to United States (US) poison centers (PCs), identified an increase in calls to PCs related to synthetic cannabinoid use. To identify risk factors and adverse health effects, CDC analyzed all calls to PCs about synthetic cannabinoid use from January to May, 2015.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom